According to the latest report by IMARC Group, titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global acne drugs market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 7.4% during 2022-2027.
Acne drugs are medications that help in reducing acne by treating its causes. They assist in reducing oil production on the skin surface and regulate skin cell turnover. Moreover, they help fight inflammation, reduce bacterial infection, treat existing blemishes, and prevent the occurrence of new acne. At present, they include retinoids, antibiotics, hormonal agents, and combination drugs, which are available in topical, oral, and injectable forms.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/acne-drugs-market/requestsample
Acne Drugs Market Trends and Drivers:
The increasing prevalence of skin diseases represents one of the primary factors positively influencing the market across the globe. In addition, rising global pollution levels are aggravating acne vulgaris and resulting in clogged pores, which make skin age faster. This, in confluence with an unhealthy diet and hormonal changes, is creating a favorable market outlook. Furthermore, the growing awareness about the availability of products containing antibiotic agents, such as creams, gels, and lotions, is bolstering the market growth around the world. Additionally, the growing influence of social media is promoting the usage of acne drugs to achieve the desired appearance, which is strengthening the market growth. Other factors like inflating disposable incomes and the easy availability of acne drugs through both online and offline distribution channels are stimulating the growth of the market worldwide.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Allergan Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- Cipher Pharmaceuticals Inc.
- Galderma Holding SA
- Johnson & Johnson
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Skinvisible Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
Acne Drugs Market Report 2022-2027 Competitive Analysis and Segmentation:
The report has segmented the market based on acne type, drug class, drug type and route of administration.
Breakup by Acne Type:
- Comedonal
- Inflammatory
- Cystic
- Postsurgical/Wound
Breakup by Drug Class:
- Retinoids
- Antibiotics
- Hormonal Agents
- Combination Drugs
- Others
Breakup by Drug Type:
- OTC Drugs
- Prescription Drugs
Breakup by Route of Administration:
- Topical
- Oral
- Injectable
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/acne-drugs-market
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group